Literature DB >> 2853758

Hypotensive action of clonidine analogues correlates with binding affinity at imidazole and not alpha-2-adrenergic receptors in the rostral ventrolateral medulla.

P Ernsberger1, R Giuliano, R N Willette, A R Granata, D J Reis.   

Abstract

Clonidine acts within the rostral ventrolateral medulla to lower arterial pressure. The receptor mechanism for this action is unknown. In the rostral ventrolateral medulla clonidine binds not only to the alpha 2-adrenergic receptor but also to a novel class of sites which are specific for imidazolines and imidazoles and are distinct from adrenergic or histaminergic receptors. In order to distinguish whether a putative imidazole receptor or the alpha 2-receptor mediates the clonidine hypotensive response, a series of clonidine analogues were tested (1) in radioligand binding assays of their affinity at imidazole and alpha 2-adrenergic receptors, and (2) by microinjection into the rostral ventrolateral medulla of anaesthetized rats to measure their capacity to lower arterial pressure. The hypotensive response elicited by the test agents was strongly correlated with affinity at imidazole sites (r = 0.92) but not with alpha 2-adrenergic affinity (r = 0.36). An imidazole receptor in the rostral ventrolateral medulla may participate in the hypotensive action of clonidine.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2853758     DOI: 10.1097/00004872-198812040-00174

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  14 in total

Review 1.  Biological significance of agmatine, an endogenous ligand at imidazoline binding sites.

Authors:  W Raasch; U Schäfer; J Chun; P Dominiak
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

2.  Clonidine-induced increase in osmolar clearance and free water clearance via activation of two distinct alpha 2-adrenoceptor sites.

Authors:  H D Intengan; D D Smyth
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

3.  The spinal antinociceptive activity of the alpha 2-adrenoceptor agonist, xylazine in sheep.

Authors:  A E Kyles; A E Waterman; A Livingston
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

4.  Moxonidine for tramadol withdrawal symptoms during detoxification.

Authors:  Farid Talih; Elias Ghossoub
Journal:  BMJ Case Rep       Date:  2015-07-08

5.  Characterization and autoradiographical localization of non-adrenoceptor idazoxan binding sites in the rat brain.

Authors:  N J Mallard; A L Hudson; D J Nutt
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

6.  A comparative study of the reversal by different alpha 2-adrenoceptor antagonists of the central sympatho-inhibitory effect of clonidine.

Authors:  C Vayssettes-Courchay; F Bouysset; A A Cordi; M Laubie; T J Verbeuren
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

7.  Effects of imidazole compounds on catecholamine release in adrenal chromaffin cells.

Authors:  M Ohara-Imaizumi; K Kumakura
Journal:  Cell Mol Neurobiol       Date:  1992-06       Impact factor: 5.046

8.  Renal imidazoline preferring sites and solute excretion in the rat.

Authors:  D R Allan; S B Penner; D D Smyth
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

Review 9.  Timing and efficacy of alternative methods of sympathetic blockade.

Authors:  Alexandros Briasoulis; George L Bakris
Journal:  Curr Hypertens Rep       Date:  2012-10       Impact factor: 5.369

10.  The role of the peripheral sympathetic nervous system in the natriuresis following central administration of an I1 imidazoline agonist, moxonidine.

Authors:  S B Penner; D D Smyth
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.